Information;Judgment — ECLI:EU:T:2023:610
Date: 2023-10-11
Language of the case: English
Court formation: First Chamber
Subject matter: Trade marks;Intellectual, industrial and commercial property
Procedure: Action for annulment - unfounded
Origin: Germany

Judgment of the General Court of 11 October 2023 – Pascoe pharmazeutische Präparate v EUIPO – Novartis Pharma (PASCELMO) (Case T-435/22) 1 (EU trade mark – Opposition proceedings – International registration designating the European Union – Word mark PASCELMO – Earlier EU word mark PASCOE – Relative ground for refusal – No likelihood of confusion – Article 8(1)(b) of Regulation (EU) 2017/1001)) Language of the case: English Parties Applicant: Pascoe pharmazeutische Präparate GmbH (Gießen, Germany) (represented by: M. Kinkeldey, S. Brandstätter, S. Clotten and C. Schmitt, lawyers) Defendant: European Union Intellectual Property Office (represented by: M. Eberl, J. Ivanauskas and V. Ruzek, acting as Agents) Other party to the proceedings before the Board of Appeal of EUIPO: Novartis Pharma AG (Basle, Switzerland) Re: By its action under Article 263 TFEU, the applicant seeks the annulment of the decision of the Second Board of Appeal of the European Union Intellectual Property Office (EUIPO) of 4 May 2022 (Case R 1890/2021-2). Operative part of the judgment The Court: 1. Dismisses the action; 2. Orders Pascoe pharmazeutische Präparate GmbH to pay the costs. ____________ 1 OJ C 326, 29.8.2022.